Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| POINT THERAPEUTICS INC | 60,000 | reported | 20 Jul 2005 | tx 1+20,000 |
| OptiNose, Inc. | 24,817 | reported | 05 Feb 2018 | tx 9+411,235−168,093 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2018 | EXERCISE | OptiNose, Inc. | 43,318 | 1.63 USD | |
| 05 Feb 2018 | EXERCISE | OptiNose, Inc. | 11,281 | 5.14 USD | |
| 05 Feb 2018 | EXERCISE | OptiNose, Inc. | 43,318 | 1.63 USD | deriv |
| 05 Feb 2018 | EXERCISE | OptiNose, Inc. | 11,281 | 5.14 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 327,757 | — | |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 10,066 | 0.00 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 20,715 | 0.00 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 82,713 | 0.00 USD | deriv |
| 12 Oct 2017 | GRANT_AWARD | OptiNose, Inc. | 28,879 | 0.00 USD | deriv |
| 20 Jul 2005 | GRANT_AWARD | POINT THERAPEUTICS INC | 20,000 | 3.86 USD | deriv |